Keyphrases
Hormone-dependent
100%
Estrogen Receptor Status
100%
Inflammatory Breast Cancer
100%
GPR30
100%
Estrogen Receptor
50%
Overall Survival
35%
Disease-free Survival
35%
Human Epidermal Growth Factor Receptor 2 (HER2)
21%
Epidermal Growth Factor Receptor
21%
Progesterone Receptor
14%
Co-expression
14%
Breast Cancer Cases
14%
Metastasis
7%
Breast Cancer
7%
Immunohistochemistry
7%
Pathologic
7%
New Drug Targets
7%
Breast Cancer Patients
7%
Ovarian Tumor
7%
Breast Tumor
7%
Estrogen Signaling
7%
Multivariate Analysis
7%
Univariate Analysis
7%
Poor Survival
7%
Estrogen Receptor-negative
7%
Endometrial Tumor
7%
Hormone-independent
7%
GPER1
7%
Breast Cancer Survival
7%
Independent Prognostic Factor
7%
Direct Modulation
7%
Medicine and Dentistry
Inflammatory Breast Cancer
100%
Receptor Expression
100%
Hormone Dependence
100%
Estrogen Receptor
100%
Disease Free Survival
45%
Overall Survival
45%
Breast Cancer
18%
Epidermal Growth Factor Receptor
18%
Progesterone Receptor
18%
Neoplasm
9%
Biological Marker
9%
Univariate Analysis
9%
Guanine Nucleotide Binding Protein
9%
Metastatic Carcinoma
9%
Multivariate Analysis
9%
Hormone
9%
Endometrium Tumor
9%
Prognostic Factor
9%
Ovarian Tumor
9%
Immunohistochemistry
9%
Pharmacology, Toxicology and Pharmaceutical Science
Estrogen Receptor
100%
Inflammatory Breast Cancer
100%
Overall Survival
45%
Disease Free Survival
45%
Breast Cancer
18%
Epidermal Growth Factor Receptor
18%
Progesterone Receptor
18%
Biological Marker
9%
Hormone
9%
Ovary Tumor
9%
Guanine Nucleotide Binding Protein
9%
Endometrium Tumor
9%
Neoplasm
9%
Neuroscience
Receptor Expression
100%
GPR30
100%
Estrogen Receptor
100%
Progesterone Receptor
14%
Epidermal Growth Factor Receptor
14%
G Protein
7%
Immunohistochemistry
7%